(Q34116281)

31 July 2017

1 reference

title

Lubeluzole for acute ischaemic stroke (English)

1 reference

31 July 2017

C Gandolfo

1

1 reference

31 July 2017

P Sandercock

series ordinal

2

1 reference

31 July 2017

M Conti

series ordinal

3

1 reference

31 July 2017

publication date

1 January 2002

1 reference

Cochrane Database of Systematic Reviews

31 July 2017

published in

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

CD001924

1 reference

Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001924

Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001924

Cardiovascular safety of lubeluzole (Prosynap(R)) in patients with ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001924

Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001924

Early clinical and radiological predictors of fatal brain swelling in ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001924

Lubeluzole treatment of acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001924

Considerations in the design of clinical trials of neuroprotective therapy in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001924

Cerestat and other NMDA antagonists in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001924

Lubeluzole blocks increases in extracellular glutamate and taurine in the peri-infarct zone in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001924

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001924

10.1002/14651858.CD001924

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference